Status:
COMPLETED
Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
PriCara, Unit of Ortho-McNeil, Inc.
Conditions:
Peripheral Neuropathy
Complex Regional Pain Syndromes (CRPS)
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The efficacy of fentanyl TTS for the treatment of neuropathic pain remains to be established, although opioids in general are clearly effective for neuropathic pain and fentanyl TTS has been shown to ...
Eligibility Criteria
Inclusion
- Age \>18 years
- Neuropathic pain persisting for \> 3 months
- Pain over the immediate previous three months
- The average of the least and usual pain intensity rating of 3 or greater (0-10 numerical rating scale) during the last week prior to enrollment
Exclusion
- A history of substance abuse
- Allergic reaction to an opioid
- Significant pain of alternate etiology other than the neuropathic pain state
- Severe pulmonary disease
- Recent myocardial infarction (within the preceding three months)
- Pregnancy
- Dementia
- Encephalopathy
- Those with life expectancy of less than six months and HIV seropositivity.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00181246
Start Date
October 1 2003
End Date
September 1 2005
Last Update
August 24 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.